相关实验视频
Updated: May 20, 2025

08:50
Predictive Immune Modeling of Solid Tumors
Published on: February 25, 2020
6.8K
从2004年到2024年,对扩散型大B细胞淋巴瘤免疫疗法的图书统计分析
Yanling Wu1,2,3, Xiaomin Chen4, Yang Liu4
1Stem Cell Immunity and Regeneration Key Laboratory of Luzhou, The Affiliated Hospital, Southwest Medical University, Luzhou, China, 1302813330@qq.com.
Acta haematologica
|March 23, 2025
概括
本文献分析揭示了扩散性大B细胞淋巴瘤 (DLBCL) 免疫治疗研究的关键趋势. 卡尔T细胞疗法是一个主要关注点,全球出版物越来越多,来自美国和中国的领先研究.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 图书统计学 图书统计学
背景情况:
- 扩散性大B细胞淋巴瘤 (DLBCL) 的免疫疗法是一个快速增长的领域,具有显著的临床潜力.
- 目前,专门分析DLBCL免疫疗法的图书统计研究有限,需要全面的概述.
研究的目的:
- 想象和分析DLBCL免疫疗法的研究热点和趋势.
- 提供有关该领域基础和临床研究未来发展的见解.
主要方法:
- 从2004年到2024年对DLBCL免疫治疗的文章和评论进行系统的搜索.
- 使用VOSviewers,CiteSpace和R包"bibliometrix"进行图书统计分析.
主要成果:
- 分析了662篇出版物,显示DLBCL免疫疗法研究的年比年增长.
- 美国和中国在出版物方面处于领先地位,德克萨斯大学MD安德森癌症中心和纪念斯隆凯特林癌症中心是顶级机构.
- 化学抗原受体T细胞 (CAR T) 疗法成为最常见的关键词,表明了一个关键的研究前沿.
结论:
- 这项研究提供了DLBCL免疫疗法研究趋势的第一个全面的文献统计总结.
- 确定了关键的研究前沿,包括CAR T细胞和双特异性抗体,为研究人员和临床医生提供了宝贵的参考资料.
相关概念视频
Tumor Immunotherapy
450
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
450
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K

